Literature DB >> 1436121

Differential coupling of 5-HT1A receptors occupied by 5-HT or 8-OH-DPAT to adenylyl cyclase.

A Varrault1, J Bockaert.   

Abstract

Human serotonin (5-hydroxytryptamine, 5-HT)-1A receptors have been transfected in NIH-3T3 cells, and their coupling to adenylyl cyclase was analysed depending on 1) the number of receptor expressed, 2) the experimental conditions used, 3) the nature of the agonists. Two monoclonal cell lines were used, expressing low (45 fmol/mg) and high (500 fmol/mg) levels of 5-HT1A receptor. Two methods were tested to study the negative coupling of the transfected 5-HT1A receptors to adenylyl cyclase: 1) measurement of cAMP production in intact cells, 2) measurement of adenylyl cyclase activity in vitro on membrane preparations. Studies on intact cells revealed that an increase in the receptor concentration was followed by 1) an increase in the efficacies of 5-HT, 5-CT (5-carboxamidotryptamine) and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), 2) a 2 to 3-fold increase in the potency of 5-CT and 8-OH-DPAT, but no change in the potency of 5-HT. In membrane preparations, 8-OH-DPAT dose-response curve was shifted leftwards when the receptor concentration became higher whereas the corresponding shift was smaller for 5-HT and absent for 5-CT. Surprisingly, on membrane preparations, 8-OH-DPAT was a partial agonist relative to 5-HT. The relative efficacy of 8-OH-DPAT was lower in the clone expressing the lowest level of receptor. This partial agonist behavior of 8-OH-DPAT could be modulated by the ionic conditions under which the adenylyl cyclase activity was measured.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1436121     DOI: 10.1007/bf00171076

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

Review 1.  The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties.

Authors:  M Hamon; H Gozlan; S el Mestikawy; M B Emerit; F Bolaños; L Schechter
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Mechanism of activation of A2 adenosine receptors. II. A restricted collision-coupling model of receptor-effector interaction.

Authors:  W Gross; M J Lohse
Journal:  Mol Pharmacol       Date:  1991-04       Impact factor: 4.436

Review 3.  Testing models of agonism for G protein-coupled receptors.

Authors:  M Keen
Journal:  Trends Pharmacol Sci       Date:  1991-10       Impact factor: 14.819

Review 4.  Analysis of agonist action using the operational model.

Authors:  P Leff
Journal:  Trends Pharmacol Sci       Date:  1988-11       Impact factor: 14.819

5.  Mechanism of A2 adenosine receptor activation. I. Blockade of A2 adenosine receptors by photoaffinity labeling.

Authors:  M J Lohse; K N Klotz; U Schwabe
Journal:  Mol Pharmacol       Date:  1991-04       Impact factor: 4.436

6.  Inhibitory action of serotonin in CA1 hippocampal neurons in vitro.

Authors:  N Ropert
Journal:  Neuroscience       Date:  1988-07       Impact factor: 3.590

7.  ATP stimulates the hydrolysis of phosphatidylethanolamine in NIH 3T3 cells. Potentiating effects of guanosine triphosphates and sphingosine.

Authors:  Z Kiss; W B Anderson
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

8.  The human 5-HT1A receptor expressed in HeLa cells stimulates sodium-dependent phosphate uptake via protein kinase C.

Authors:  J R Raymond; A Fargin; J P Middleton; J M Graff; D M Haupt; M G Caron; R J Lefkowitz; V W Dennis
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

9.  Neurohypophyseal hormone-responsive renal adenylate cyclase. IV. A random-hit matrix model for coupline in a hormone-sensitive adenylate cyclase system.

Authors:  R N Bergman; O Hechter
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

10.  Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons.

Authors:  J Bockaert; A Dumuis; R Bouhelal; M Sebben; R N Cory
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

View more
  4 in total

Review 1.  The recombinant 5-HT1A receptor: G protein coupling and signalling pathways.

Authors:  J R Raymond; Y V Mukhin; T W Gettys; M N Garnovskaya
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists.

Authors:  S M Candura; E Messori; G P Franceschetti; G D'Agostino; D Vicini; M Tagliani; M Tonini
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

3.  BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex.

Authors:  F Borsini; E Giraldo; E Monferini; G Antonini; M Parenti; G Bietti; A Donetti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-09       Impact factor: 3.000

4.  Functional characterization of cannabidiol effect on the serotonergic neurons of the dorsal raphe nucleus in rat brain slices.

Authors:  Aitziber Mendiguren; Erik Aostri; Elena Alberdi; Alberto Pérez-Samartín; Joseba Pineda
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.